From the Journals

Axial SpA disease activity remains mostly stable throughout pregnancy

Publish date: March 23, 2018

 

FROM RHEUMATOLOGY


“Future research on pregnancy in women with axSpA should differentiate between subgroups of the disease and aim to include objective assessment of inflammation.”

The study was funded by the Research Fund of the Norwegian Organization for People With Rheumatic Diseases. None of the authors had any conflicts of interest to declare.

Pages

Recommended Reading

Ultrasound’s value for arthralgia may be to rule out IA
MDedge Family Medicine
Launch of adalimumab biosimilar Amjevita postponed
MDedge Family Medicine
Biosimilars poised to save $54 billion over the next decade
MDedge Family Medicine
VIDEO: Beware of over-relying on MRI findings in axSpA
MDedge Family Medicine
Flare of nonradiographic axial SpA occurs often after adalimumab withdrawal for remission
MDedge Family Medicine
Testing for latent tuberculosis infection
MDedge Family Medicine
FDA approves infliximab biosimilar Ixifi for all of Remicade’s indications
MDedge Family Medicine
Arthritis limits physical activity the most in the South
MDedge Family Medicine
Maternal biologic therapy does not affect infant vaccine responses
MDedge Family Medicine
FDA approves certolizumab label update for pregnancy, breastfeeding
MDedge Family Medicine

Related Articles